ConductScience.org, home

Paper36727232

[MicroRNA 424-5p promotes the sensitivity of hepatocellular carcinoma cells to sorafenib by targeting Kinesin family member 23].

Liu XL and 4 others. Zhonghua Gan Zang Bing Za Zhi, 2022. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. [MicroRNA 424-5p promotes the sensitivity of hepatocellular carcinoma cells to sorafenib by targeting Kinesin family member 23]. Papers, record 36727232. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36727232

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
[MicroRNA 424-5p promotes the sensitivity of hepatocellular carcinoma cells to sorafenib by targeting Kinesin family member 23].
PubMed
Journal
Zhonghua Gan Zang Bing Za Zhi
PubMed
Year
2022
PubMed
Publication types
English Abstract, Journal Article
PubMed
Citations, by iCite
2
iCite
Relative citation ratio, by iCite
0.17
iCite
Revised in PubMed
2026-09-19
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Liu XLX L
2Sun CFC F
3Yuan YY
4Sheng YJY J
5Deng CLC L

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, HepatocellularMajor topic
Liver NeoplasmsMajor topic
MicroRNAsMajor topic
Microtubule-Associated ProteinsMajor topic
Humans
Cell Movement
Cell Proliferation
Family
Gene Expression Regulation, Neoplastic
Kinesins
Sorafenib
Hep G2 Cells

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
2018KZ0049Science and Technology Project of SichuanPubMed

Source PubMed

Download CSV of grants

References15

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132832397Management and Treatment of Hepatocellular Carcinoma with Immunotherapy: A Review of Current and Future Options.J Clin Transl Hepatol2020https://conductscience.org/library/papers/32832397PubMed
232520206MicroRNA-424-5p inhibits the proliferation, migration, and invasion of nasopharyngeal carcinoma cells by decreasing AKT3 expression.Braz J Med Biol Res2020https://conductscience.org/library/papers/32520206PubMed
333313139KIF23 enhances cell proliferation in pancreatic ductal adenocarcinoma and is a potent therapeutic target.Ann Transl Med2020https://conductscience.org/library/papers/33313139PubMed
434014023MiR-17-5p downregulation alleviates apoptosis and fibrosis in high glucose-induced human mesangial cells through inactivation of Wnt/β-catenin signaling by targeting KIF23.Environ Toxicol2021https://conductscience.org/library/papers/34014023PubMed
534107580[Effect of miR-23b on the malignant phenotype and the sensitivity of lenvatinib in human hepatocellular carcinoma cells].Zhonghua Gan Zang Bing Za Zhi2021https://conductscience.org/library/papers/34107580PubMed
634966644MicroRNA-7-5p Inhibits Migration, Invasion and Metastasis of Intrahepatic Cholangiocarcinoma by Inhibiting MyD88.J Clin Transl Hepatol2021https://conductscience.org/library/papers/34966644PubMed
734268078KIF23 promotes triple negative breast cancer through activating epithelial-mesenchymal transition.Gland Surg2021https://conductscience.org/library/papers/34268078PubMed
831135262Methylation-mediated repression of MiR-424/503 cluster promotes proliferation and migration of ovarian cancer cells through targeting the hub gene KIF23.Cell Cycle2019https://conductscience.org/library/papers/31135262PubMed
931360102miR-424-5p represses the metastasis and invasion of intrahepatic cholangiocarcinoma by targeting ARK5.Int J Biol Sci2019https://conductscience.org/library/papers/31360102PubMed
1031594104[Advances in the study of programmed cell death protein 1 and its ligand inhibitors in the treatment of late stage HCC].Zhonghua Gan Zang Bing Za Zhi2019https://conductscience.org/library/papers/31594104PubMed
1131007778KIF23 Promotes Gastric Cancer by Stimulating Cell Proliferation.Dis Markers2019https://conductscience.org/library/papers/31007778PubMed
1234722189Hepatocellular Carcinoma and the Role of Liver Transplantation: A Review.J Clin Transl Hepatol2021https://conductscience.org/library/papers/34722189PubMed
1332138313Regulatory Mechanism of MicroRNA Expression in Cancer.Int J Mol Sci2020https://conductscience.org/library/papers/32138313PubMed
1434381736Hsa-miR-4277 Decelerates the Metabolism or Clearance of Sorafenib in HCC Cells and Enhances the Sensitivity of HCC Cells to Sorafenib by Targeting cyp3a4.Front Oncol2021https://conductscience.org/library/papers/34381736PubMed
1533754001Aberrant KIF23 expression is associated with adverse clinical outcome and promotes cellular malignant behavior through the Wnt/β-catenin signaling pathway in Colorectal Cancer.J Cancer2021https://conductscience.org/library/papers/33754001PubMed

Download CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
42410612KIF23 in disease pathogenesis and therapeutics : from molecular mechanisms to clinical translation.Cancer Cell Int2026https://conductscience.org/library/papers/42410612PubMed
42178466KIF23 in disease pathogenesis and its therapeutic and diagnostic potential.Discov Oncol2026https://conductscience.org/library/papers/42178466PubMed
38433242The role of kinesin family members in hepatobiliary carcinomas: from bench to bedside.Biomark Res2024https://conductscience.org/library/papers/38433242PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
KIF239493PubTator's text mininghttps://conductscience.org/library/genes/9493NCBI Gene
MIR424494336PubTator's text mininghttps://conductscience.org/library/genes/494336NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36727232

GET https://conductscience.org/api/papers/v1/36727232/authors